Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Leveraging the advances in HIV for COVID-19

The Lancet(2020)10.1016/s0140-6736(20)32012-2Source: DataRank Database

Leveraging the advances in HIV for COVID-19 is a research paper published in The Lancet (2020). On theSindex it has a DataRank of 0. It has been cited 10 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access10 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)OA: hybridTopics (30)IDs (PubMed, PMC)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Jennifer Hoy ORCID,Adeeba Kamarulzaman ORCID,Linda‐Gail Bekker ORCID,Chris Beyrer ORCID,Sharon R. Lewin ORCID

Live enrichment

PubMed:33010825 PMC:PMC7529395

Wellcome Trust

Grant: unidentified

unidentified

Wellcome Trust

hybridLicense: Elsevier TDM

publisherhttps://api.elsevier.com/content/article/PII:S0140673620320122?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0140673620320122?httpAccept=text/plain

Europe_PMChttps://europepmc.org/articles/PMC7529395

Europe_PMChttps://europepmc.org/articles/PMC7529395?pdf=render

https://doi.org/10.1016/s0140-6736(20)32012-2

Fields of Study

03 medical and health sciences0302 clinical medicine

MeSH Terms

HumansPneumonia, ViralCoronavirus InfectionsHIV InfectionsAIDS VaccinesAntiviral AgentsRisk FactorsVulnerable PopulationsPandemicsGlobal HealthBetacoronavirusCOVID-19SARS-CoV-2

Keywords

AIDS VaccinesSARS-CoV-2CommentPneumonia, ViralCOVID-19HIV InfectionsGeneral MedicineGlobal HealthAntiviral AgentsVulnerable PopulationsBetacoronavirusRisk FactorsHumansCoronavirus InfectionsPandemics

Sustainable Development Goals

SDG 3: 3. Good health